Pure Red Cell Aplasia
📧 Sign up to get email alerts when something new happens for Pure Red Cell Aplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: The Use of Trifluoperazine in Transfusion Dependent DBA [Phase 1, Phase 2]
Phase 1/2 trial of trifluoperazine for transfusion-dependent Diamond Blackfan Anemia and Pure Red Cell Aplasia was terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Sirolimus Treatment for Refractory PRCA [Phase 4]
Phase 4 clinical trial update on sirolimus for refractory Pure Red Cell Aplasia has been completed.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Tacrolimus Treatment for Refractory Autoimmune Cytopenia [Phase 4]
A Phase 4 clinical trial update evaluating tacrolimus for refractory autoimmune cytopenia, including autoimmune hemolytic anemia and pure re…
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins
A completed clinical trial update assessing how many patients develop pure red cell aplasia while receiving epoetin alfa or other recombinan…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure [Phase 2]
Phase 2 trial evaluating daclizumab for bone marrow failure (aplastic anemia and related conditions) was terminated; results posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin
This completed clinical trial monitors the incidence of pure red cell aplasia and antibodies to erythropoietin among participants receiving …
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure
A completed surveillance study to estimate the incidence of pure red cell aplasia in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia [Phase 2]
Phase 2 trial update for rituximab in treating moderate aplastic anemia, pure red cell aplasia, or Diamond-Blackfan anemia with completed st…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment [Phase 3]
Phase 3 study evaluating treatment for anti-r-HuEpo–associated pure red cell aplasia has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes [Phase 2]
Phase 2 trial update of an allogeneic mixed chimerism stem cell transplant using Campath (alemtuzumab) for hemoglobinopathies and bone marro…
-
CLINICAL_TRIALS trial_result · 2013-04-30Clinical Trial Update: A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
A completed clinical trial investigating risk factors for anti-erythropoietin antibodies leading to pure red-cell aplasia in patients with c…
-
CLINICAL_TRIALS trial_result · 2013-04-30Clinical Trial Update: A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment
A completed clinical trial investigating pure red cell aplasia associated with recombinant human erythropoietin treatment.